Non-insulin-dependent diabetes mellitus. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: intervention: 15 grams of powdered fenugreek seeds in doses of 5 grams three times a day between meals, dissolved in water, besides routine diabetic drugs, for 8 weeks. Intervention 2:
Treatment - Other
Treatment - Drugs
intervention: 15 grams of powdered fenugreek seeds in doses of 5 grams three times a day between meals, dissolved in water, besides routine diabetic drugs, for 8 weeks
control: routine diabetic drugs for 8 weeks
Sponsors
Vice chancellor for research, Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: type 2 diabetes; 30-65 years old; at least 1 year and up to 10 year diabetic history; Body Mass Index<35 Exclusion criteria: insulin therapy; menopause or hysterectomy for women; having any certain diseases or using any certain medications other than diabetic ones; allergy to Fabaceae family herbs; using dietary supplements and other medicinal plants for at least three months prior to the study; smoking or using drugs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hip circumference. Timepoint: baseline and 8 weeks after intervention. Method of measurement: measuring tape.;Waist circumference. Timepoint: baseline and 8 weeks after intervention. Method of measurement: measuring tape.;Blood pressure. Timepoint: baseline and 8 weeks after intervention. Method of measurement: sphygmomanometer.;Alanine Amino Transferase. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Aspartate aminotransferase. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Alkaline phosphatase. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Blood urea nitrogen. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Creatinine. Timepoint: baseline and 8 weeks after intervention. Method of measurement: blood sampling and commercial kits.;Depression. Timepoint: baseline and 8 weeks after intervention. Method of measurement: "Hospital Anxiety and Depression Scale" questionnaire.;Anxiety. Timepoint: baseline and 8 weeks after intervention. Method of measurement: "Hospital Anxiety and Depression Scale" questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Lipid accumulation product index. Timepoint: baseline and 8 weeks after intervention. Method of measurement: Formula calculation.;Estimated glomerular filtration rate. Timepoint: baseline and 8 weeks after intervention. Method of measurement: Formula calculation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRahele tavakoly
Isfahan University of Medical Sciences
Outcome results
None listed